Webpages tagged with «Helse»
In conjunction with the 7th CCBIO Symposium Omid Farokzhad will deliver a Volterra lecture Tuesday May 14th titled "Perspectives on how to Translate Biomedical Research to Products and Cures" The lecture is held at Solstrand Hotel&Bad near Bergen and is open for everyone.
Combining computational and experimental approaches, MIT-Professor Christopher Voigt has made outstanding contributions to the fields of synthetic biology and biological engineering. In the beginning of May he guests our Volterra Lecture Series in Oslo, Trondheim and Bergen, to offer his approach on programming cells.
Computational approaches that can aid our understanding of cancer development are improving. Are we approaching the time when computer simulations could become a clinical tool in cancer treatment?
The goals of this symposium is to connect people and groups working within different areas of relevance to systems medicine to share information, find new partners, solve problems and to be inspired to apply for funding from future calls. We also want to get input from Norwegian research environments with regards to what needs to be in place to advance this field further.
10 May 2019, Industrial PhD candidate Odd Martin Staal will publicly defend his PhD degree at NTNU.
Are you interested in innovative solutions for patient centric healthcare and remote care delivery? Are you delivering solutions for this sector? Then join Norway Health Tech's demo day.
Prof Nikolas Rose will focus on how modern neuroscience and attention towards brain function and mental health changes how we perceive ourselves
The centre welcomes Professor Natasa Pruzlj of Biomedical Data Science at UCL to give her Volterra lecture on Friday 28 September at NTNU. She will discuss linking heterogeneous data in the biomedical domain.
In conjugation with the PhD course Metabolomics- Methods and Applications, there will be a mini-seminar open for everyone.
The course builds on approaches and technologies that we are currently developing in the NTNU DrugLogics initiative, where we use the logical modelling formalism for predicting the outcome of chemical perturbations (cancer drugs) on cancer cell fate decisions. This approach combines knowledge management, logical model construction and computational simulation with experimental assays and hypothesis testing for pre-clinical (biotechnological) drug development and clinical decision support. The course will exemplify how such approaches can be used in both the biotechnological and biomedical sectors such as pre-clinical drug discovery and repurposing, and clinical development of diagnosis and (combinatorial) treatment of cancer.
Friday 7 Dec 2018, APT member Konstanze Kölle will have her public PhD defence at NTNU.
Professor Jerome S. Engel is an internationally recognized expert on innovation, entrepreneurship, and venture capital, lecturing and advising business and government leaders around the world. Most recently he has focused on lean innovation entrepreneurship and developing innovation ecosystems globally. In the current event, he will share his insights on how this can be part of innovation in biology, health care and life science.
The Centre for Digital Life Norway welcomes all interested to a public lecture on the role of neuroscience for the future of psychiatry by the prominent British sociologist Nikolas Rose. He will address questions such as: Where does the current scientific and popular attention to the human brain come from? Does it change how we understand ourselves? And where are the social sciences and humanities in all of this?
Welcome to this guest lecture 9 May held by Professor Ali Cinar (Illinois Institute of Technology). He will visit NTNU, Trondheim as an opponent for Odd Martin Staal’s PhD defence, scheduled for 10 May.
Welcome to this guest lecture 6 December held by Dr Chiara Toffanin (University of Pavia, Italy). She will visit NTNU, Trondheim as an opponent for Konstanze Kölle’s PhD defence, scheduled for 7 December.
This year's innovation day is part of the Life science Technology & Business Conference - " 37° - Digitalising Health", 19 - 20 June 2018, Stavanger, Norway.
This time Professor Nathalie Reuter will give a presentation of the Biotek2021 funded project and the use of computational biology methods for drug discovery against Chronic Obstructive Pulmonary Disease (COPD).
Professor Bonnie Berger is the Simons Professor of Mathematics at MIT, holds a joint appointment in Electrical Engineering and Computer Science, and serves as head of Computation and Biology group at MIT's Computer Science and AI Lab. Her recent work focuses on designing algorithms to gain biological insights from advances in automated data collection and the subsequent large data sets drawn from them. She works on a diverse set of problems, including Compressive Genomics, Network Inference, Structural Bioinformatics, Genomic Privacy, and Medical Genomics. Additionally, she collaborates closely with biologists in order to design experiments to maximally leverage the power of computation for biological explorations.
The invited Volterra Lecture at UiT co-hosted by DigiBiotics is given by Prof Inger Sandlie who successfully have combined the role as innovator and researcher.
Artificial Intelligence (AI) is often mentioned as the solution to many of our future challenges, also within healthcare, and in January 2020 the Norwegian Government launched a National Strategy for Artificial Intelligence. What role could AI play in cancer diagnostics? How should diagnoses be set in the future, and which new questions might arise when introducing new technologies?
Welcome to an academia-industry meeting day, AIMday®, focused on the use of machine learning in life science and medicine. Machine learning, in which systems automatically learn complex patterns in data, and improve from experience, is becoming an essential tool in healthcare diagnosis, treatment and care, as well as in medical research.
Together with the Double Intraperitoneal Artificial Pancreas project the Centre welcomes Professor Francis J. Doyle III, Dean of John A. Paulson School of Engineering and Applied Sciences (SEAS), Harvard University, and scholar in chemical engineering to present his latest work on testing algorithms in clinical settings for an artificial pancreas and the future technology for the millions of individuals who are affected by Type 1 diabetes mellitus (T1DM). Prof Doyle has devoted his research to understand and characterize biological systems by a systems engineering approach, contributing to the fields of systems biology and functional biomedical control, while combining computational and experimental work.